Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
PRME
#2265
Prime Medicine, Inc. Common Stock
4.6
2
+7.94%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+7.94%
Aylık değişim
+6.21%
6 aylık değişim
+35.48%
Yıllık değişim
+87.04%
Önceki kapanış
4.2
8
Open
4.6
2
Bid
Ask
Low
4.6
2
High
4.6
2
Hacim
111
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
PRME
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
131.16 M
131.16 M
131.29 M
134.57 M
180.51 M
—
Valuation ratios
Enterprise value
389.62 M
200.51 M
169.4 M
278.59 M
928.63 M
1.58 B
Price to earnings ratio
-1.88
-1.77
-1.24
-1.58
-3.85
-8.44
Price to sales ratio
—
116.1
63.5
61.72
117.89
359.19
Price to cash flow ratio
-2.19
-2.82
-2.29
-3.15
-6.84
-15.09
Price to book ratio
0.54
2.26
0.36
0.58
1.48
4.68
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.16
0.14
0.16
0.19
0.13
0.62
Return on equity %
0.28
0.28
0.49
0.86
0.31
1.94
Return on invested capital %
191.8
154.15
151.97
121.05
—
—
Gross margin %
100
100
100
100
100
400
Operating margin %
25.95 K
2 025.74
3 603.3
4 787.17
4 405.96
14.82 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
25.13 K
1 936.6
3 568.78
4 716.68
4 129.14
14.35 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
6.5
5.58
4.78
3.56
6.61
20.52
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0.01
0
0
0
0.02
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.22
-0.14
0.37
0.32
0.22
0.78
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.47
1.61
1.1
0.79
1.33
4.82
Net current asset value per share
2.05
1.79
1.25
0.94
1.44
5.42
Tangible book value per share
1.58
1.29
0.82
0.47
1.01
3.59
Working capital per share
1.74
1.47
0.99
0.67
1.22
4.35
Book value per share
1.58
1.29
0.82
0.47
1.01
3.59
Haberler
Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Lags Revenue Estimates
Prime Drink Group özel yerleşim işleminin ilk kapanışını tamamladı
Prime Drink Group completes first closing of private placement
Prime: Maintaining "Buy" On Solidified Catalysts For Wilson's Disease And Beyond
Prime Drink Group 5 milyon dolara kadar fon toplamak için özel yerleşim duyurdu
Prime Drink Group announces private placement to raise up to $5 million
Goldman Sachs, Prime Medicine hissesi için Erken Aşama Biyoteknoloji notunu yineledi
Goldman Sachs reiterates Early-Stage Biotech rating on Prime Medicine stock
Prime Medicine, Inc. (PRME) Reports Q3 Loss, Lags Revenue Estimates
Prime Medicine appoints Matthew Hawryluk as chief business officer
NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates
Prime Medicine Momentum Amid Pipeline Progress: Why I Choose To 'Hold' For Now (PRME)